Lionsgate
Major mini-studio focused on commercial genre franchises (John Wick, Rambo, Hunger Games, Saw), with a wide acquisition mandate spanning action, horror, thriller, drama, and unscripted.
Each signal is one documented data point captured by our continuous pipeline: a trade-press mention, festival market activity, executive statement, or acquisition activity update. Higher signal volume means Lionsgate is generating more public market activity right now.
A franchise-IP-driven mini-studio with one of the broadest commercial genre mandates in the U.S. distribution market. The Continental, the Rambo TV slate, and the eOne integration anchor 2025-26 strategy.
Lionsgate enters mid-2026 as one of the most franchise-IP-driven commercial studios in the U.S. market. The company's positioning continues to lean into established franchises: John Wick (with the Continental TV spinoff in market on Peacock and Amazon, plus second-window sales at Mipcom), the Rambo television slate (acquired full TV rights to all future Rambo projects in November 2025), and ongoing exploitation of Hunger Games, Saw, and other long-running properties. The recent ~$500M acquisition of Hasbro's eOne added a substantial library and additional unscripted capability.
The acquisition mandate is genuinely wide. Lionsgate buys commercial genre films across horror, action, thriller, and drama, plus prestige biopics, mid-budget theatrical features, and unscripted genre content. Recent acquisitions span the Hurry Up Tomorrow theatrical pickup, the Canadian theatrical distribution deal with Cineplex Pictures (11-title 2023 slate), and ongoing library exploitation deals. The company maintains both domestic and international distribution channels, with active multi-territory deals through partners like CJ ENM and other co-production financiers.
Access pattern is studio-conventional: rep-only at the door, with established producer attachments and sales-agent relationships as the dominant pathway. Lionsgate's commercial mandate makes it more receptive than pure-specialty labels to genre material with cast attachments and franchise IP potential. Budget tolerance spans from sub-$5M genre pickups through $30M+ mid-budget commercial features and into the high-budget franchise tier. The company's appetite for IP makes it an active buyer of book rights, comic adaptations, and remake opportunities.
All future Rambo television projects
Canadian theatrical distribution agreement with Cineplex Pictures for Lionsgate's 2023 slate (11 titles)
eOne
Fall
Hurry Up Tomorrow
John Rambo
John Rambo (upcoming sixth installment of the Rambo film series)
John Rambo (worldwide distribution rights to sixth installment)
A franchise-IP-driven mini-studio with one of the broadest commercial genre mandates in the U.S. distribution market. The Continental, the Rambo TV slate, and the eOne integration anchor 2025-26 strategy.
Studios reinforcing franchise marketing leadership to maximize ROI on established IP; genre films ($400M+ for The Housemaid) proving mid-budget theatrical viability
You just read about Lionsgate.
Now find out if Lionsgate should be reading you.
This page is a public snapshot of Lionsgate, kept fresh from trade-press signals. ScriptMatch is the live market-data engine behind it. Upload your script, and we use the same continuously-indexed buyer activity to tell you which production companies and distributors are actively acquiring projects like yours right now, why each one fits, and exactly how to reach them.
- ✓Your first 10 AI-matched buyers for your script, with match rationale and pathway recommendations
- ✓Full access to the buyer intelligence layer — recent acquisitions, executive moves, stated mandates
- ✓Email enrichment for matched development executives
- ✓Script tracking dashboard + market alerts for 7 days
Does Lionsgate accept unsolicited scripts?
No. Lionsgate operates as a rep-only buyer at intake. The company does not maintain an open submission portal. Material reaches Lionsgate through three primary pathways: established literary representation (agency or management), an attached producer with a working Lionsgate or franchise-IP relationship, or sales-agent packaging for completed films.
What budgets does Lionsgate typically work at?
Wide range. Genre pickups (horror, low-budget thriller) land in the sub-$5M acquisition price range. Mid-budget commercial features cluster in the $10M to $30M tier. Franchise IP and tentpole productions reach $50M+ budgets. The company is comfortable across the full commercial-studio spectrum and has both theatrical and direct-to-platform distribution capability.
What festivals does Lionsgate source from?
Less festival-driven than specialty labels. Lionsgate is active at major U.S. and European markets (AFM, Berlin EFM, Cannes Marché du Film, Mipcom for TV) where the company packages multi-territory rights and acquires completed films. Festival pickups happen but are not the primary sourcing channel.
How do I get my script in front of Lionsgate?
Two realistic pathways: literary representation through a major agency or management company that already has access, or producer packaging with attached talent (cast, director) that fits Lionsgate's commercial mandate. The company is more receptive to material with clear franchise or commercial-genre positioning than to pure specialty drama. Direct cold query has zero conversion.
What genres is Lionsgate currently acquiring?
Commercial genre (action, horror, thriller), franchise IP and remake opportunities, mid-budget drama with cast packaging, prestige biopics, and unscripted television (expanded via the eOne integration). The recent focus has been TV franchise expansion (The Continental, Rambo TV) alongside continued theatrical commercial output.
Is Lionsgate currently active in the market?
Yes, at high volume. Lionsgate has documented 648 signals over the past 12 months — among the highest-volume buyers we track. The eOne acquisition added substantial library and unscripted capability. The company's positioning as one of the few remaining mid-major commercial studios makes it an active acquirer across genre, franchise, and mid-budget theatrical material.
Profile compiled from publicly-available sources: trade press (Deadline, Variety, IndieWire, The Hollywood Reporter, Screen Daily), festival market reports (Cannes Marche, AFM, EFM, TIFF Industry), executive public statements, and acquisition announcements. Activity counters reflect signal volume from continuous pipeline indexing.
See an inaccuracy? Suggest a correction. Profiles update continuously as new public information becomes available.